Baric Transcribed Interview (Redacted) — page 79
of 155 pages
← p.78 p.80 → · this page in the original PDF · package
DC.Scheduling@LexitasLegal.com
sequenced, and they had no other sequences of related
viruses. There was a rumor that a pangolin virus existed
with 100 percent identity, or close to 100 percent identity
to SARS-2. That turned out not to be true, as the
pangolin, called the pangolin GD strain, which was about 90
percent identical, I believe, is the virus they were
talking about. It has a receptor binding domain that is
almost identical, nearly identical to SARS-2, but it does
have a couple point mutations in it. And the reason that's
important is that that meant that there were natural
isolates in nature that had that sequence, which means it's
not engineered.
MS. SALAZAR: Okay.
DR. BARIC: It was later then found that the BANAL
strains on the Cambodian-Thailand-Chinese border --
MS. SALAZAR: This is --
DR. BARIC: BANAL-52 and BANAL-1-something or another,
also had receptor binding domains that were virtually
identical to SARS-2. So there's two bad viruses and
pangolin virus within the clade, within that branch of
SARS-2 that had identical receptor binding domains, which
means that it's not engineered.
MS. SALAZAR: Would your opinion change if you knew
that they WIV was conducting work on pangolin viruses
around 2019, 2018?
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/baric_ti/79
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| baric_ti:utt:00701 | 2026-04-10 | transcript segment | 78–79 |
| baric_ti:utt:00702 | 2026-04-10 | transcript segment | 79 |
| baric_ti:utt:00703 | 2026-04-10 | transcript segment | 79 |
| baric_ti:utt:00704 | 2026-04-10 | transcript segment | 79 |
| baric_ti:utt:00705 | 2026-04-10 | transcript segment | 79 |
| baric_ti:utt:00706 | 2026-04-10 | transcript segment | 79–80 |